October 19, 2017
Formerly the animal facility laboratory supervisor at the Africa Health Research Institute in Durban, South Africa, Chivonne Moodley is now joining a Tulane University tuberculosis research team.
October 13, 2017
Tulane researchers Robert Garry and James Robinson won’t give up until they unravel the mystery of the Lassa virus, saving lives from a severe and often fatal hemorrhagic fever that infects more than 300,000 people annually and is wrecking West African communities.
October 04, 2017
Elk Place Health Spot is a free monthly event where the public can obtain services such as vision tests and 1-minute HIV screening along with the chance to pick up a healthy snack and learn about topics like backyard mosquito control.
October 03, 2017
Researchers in the Tulane National Primate Research Center want to know more about why patients with HIV are highly susceptible to contracting tuberculosis (TB). Using two new grants, totaling $8.4 million from the National Institute of Allergy and Infectious Diseases, the Tulane team lead by Deepak Kaushal hopes to figure out how the bacterium that causes TB invades T-cells depleted by HIV. The researchers will also study if B-cells can be a source of protection against tuberculosis for patients battling HIV.
September 26, 2017
The National Institutes of Health has awarded Tulane University a five-year, $6.28 million grant to test ways to best implement new guidelines to more aggressively manage high blood pressure in adults, especially among low-income patients at high risk for cardiovascular disease.
September 26, 2017
A Tulane University geologist has concluded a study on climate change, which will help develop climate models that simulate the effects of climate change and the Earth’s response to it.
September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published online in The Lancet Infectious Diseases.
September 05, 2017
An experimental therapy using cloned antibodies from Lassa fever survivors was 100 percent effective in stopping the progression of the deadly disease in nonhuman primates up to eight days after infection, according to a new study in Nature Medicine.
September 01, 2017
Rickey Jackson, along with several other New Orleans Saints legends, is partnering with Tulane Health System for a second year to raise awareness of prostate cancer and provide free PSA screenings to any eligible men.